Literature DB >> 22721696

Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.

Anbarasi Kothandapani1, Kathirvel Gopalakrishnan, Bhaskar Kahali, David Reisman, Steve M Patrick.   

Abstract

Chromatin remodeling complex SWI/SNF plays important roles in many cellular processes including transcription, proliferation, differentiation and DNA repair. In this report, we investigated the role of SWI/SNF catalytic subunits Brg1 and Brm in the cellular response to cisplatin in lung cancer and head/neck cancer cells. Stable knockdown of Brg1 and Brm enhanced cellular sensitivity to cisplatin. Repair kinetics of cisplatin DNA adducts revealed that downregulation of Brg1 and Brm impeded the repair of both intrastrand adducts and interstrand crosslinks (ICLs). Cisplatin ICL-induced DNA double strand break repair was also decreased in Brg1 and Brm depleted cells. Altered checkpoint activation with enhanced apoptosis as well as impaired chromatin relaxation was observed in Brg1 and Brm deficient cells. Downregulation of Brg1 and Brm did not affect the recruitment of DNA damage recognition factor XPC to cisplatin DNA lesions, but affected ERCC1 recruitment, which is involved in the later stages of DNA repair. Based on these results, we propose that SWI/SNF chromatin remodeling complex modulates cisplatin cytotoxicity by facilitating efficient repair of the cisplatin DNA lesions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22721696      PMCID: PMC3408789          DOI: 10.1016/j.yexcr.2012.06.011

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  47 in total

1.  The chromatin remodeling factor BRG1 stimulates nucleotide excision repair by facilitating recruitment of XPC to sites of DNA damage.

Authors:  Ling Zhang; Qian Zhang; Kristi Jones; Mausam Patel; Feng Gong
Journal:  Cell Cycle       Date:  2009-12       Impact factor: 4.534

2.  Photo-cross-linking of XPC-Rad23B to cisplatin-damaged DNA reveals contacts with both strands of the DNA duplex and spans the DNA adduct.

Authors:  Tracy M Neher; Nadejda I Rechkunova; Olga I Lavrik; John J Turchi
Journal:  Biochemistry       Date:  2010-02-02       Impact factor: 3.162

3.  BRG-1 is required for RB-mediated cell cycle arrest.

Authors:  M W Strobeck; K E Knudsen; A F Fribourg; M F DeCristofaro; B E Weissman; A N Imbalzano; E S Knudsen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

4.  BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.

Authors:  A K Wong; F Shanahan; Y Chen; L Lian; P Ha; K Hendricks; S Ghaffari; D Iliev; B Penn; A M Woodland; R Smith; G Salada; A Carillo; K Laity; J Gupte; B Swedlund; S V Tavtigian; D H Teng; E Lees
Journal:  Cancer Res       Date:  2000-11-01       Impact factor: 12.701

5.  BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer.

Authors:  D A Bochar; L Wang; H Beniya; A Kinev; Y Xue; W S Lane; W Wang; F Kashanchi; R Shiekhattar
Journal:  Cell       Date:  2000-07-21       Impact factor: 41.582

6.  Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells.

Authors:  Sanjeevani Arora; Anbarasi Kothandapani; Kristin Tillison; Vivian Kalman-Maltese; Steve M Patrick
Journal:  DNA Repair (Amst)       Date:  2010-04-24

7.  Increased DNA damage sensitivity and apoptosis in cells lacking the Snf5/Ini1 subunit of the SWI/SNF chromatin remodeling complex.

Authors:  Agnes Klochendler-Yeivin; Eli Picarsky; Moshe Yaniv
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Modulation of extracellular matrix/adhesion molecule expression by BRG1 is associated with increased melanoma invasiveness.

Authors:  Srinivas Vinod Saladi; Bridget Keenen; Himangi G Marathe; Huiling Qi; Khew-Voon Chin; Ivana L de la Serna
Journal:  Mol Cancer       Date:  2010-10-22       Impact factor: 27.401

9.  The ERCC1/XPF endonuclease is required for completion of homologous recombination at DNA replication forks stalled by inter-strand cross-links.

Authors:  Ali Z Al-Minawi; Yin-Fai Lee; Daniel Håkansson; Fredrik Johansson; Cecilia Lundin; Nasrollah Saleh-Gohari; Niklas Schultz; Dag Jenssen; Helen E Bryant; Mark Meuth; John M Hinz; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2009-08-27       Impact factor: 16.971

10.  Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.

Authors:  B Keenen; H Qi; S V Saladi; M Yeung; I L de la Serna
Journal:  Oncogene       Date:  2009-09-28       Impact factor: 9.867

View more
  31 in total

Review 1.  Targeting DNA repair in cancer: current state and novel approaches.

Authors:  Apostolos Klinakis; Dimitris Karagiannis; Theodoros Rampias
Journal:  Cell Mol Life Sci       Date:  2019-10-14       Impact factor: 9.261

2.  Brg1 Controls the Expression of Pax7 to Promote Viability and Proliferation of Mouse Primary Myoblasts.

Authors:  Teresita Padilla-Benavides; Brian T Nasipak; Anthony N Imbalzano
Journal:  J Cell Physiol       Date:  2015-12       Impact factor: 6.384

Review 3.  Nucleosome remodelling, DNA repair and transcriptional regulation build negative feedback loops in cancer and cellular ageing.

Authors:  Reiko Watanabe; Shin-Ichiro Kanno; Amaneh Mohammadi Roushandeh; Ayako Ui; Akira Yasui
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-05       Impact factor: 6.237

4.  Gene silencing associated with SWI/SNF complex loss during NSCLC development.

Authors:  Shujie Song; Vonn Walter; Mehmet Karaca; Ying Li; Christopher S Bartlett; Dominic J Smiraglia; Daniel Serber; Christopher D Sproul; Christoph Plass; Jiren Zhang; D Neil Hayes; Yanfang Zheng; Bernard E Weissman
Journal:  Mol Cancer Res       Date:  2014-01-20       Impact factor: 5.852

5.  BRM Promoter Polymorphisms and Survival of Advanced Non-Small Cell Lung Cancer Patients in the Princess Margaret Cohort and CCTG BR.24 Trial.

Authors:  Geoffrey Liu; Sinead Cuffe; Shermi Liang; Abul Kalam Azad; Lu Cheng; Yonathan Brhane; Xin Qiu; David W Cescon; Jeffrey Bruce; Zhuo Chen; Dangxiao Cheng; Devalben Patel; Brandon C Tse; Scott A Laurie; Glenwood Goss; Natasha B Leighl; Rayjean Hung; Penelope A Bradbury; Lesley Seymour; Frances A Shepherd; Ming Sound Tsao; Bingshu E Chen; Wei Xu; David N Reisman
Journal:  Clin Cancer Res       Date:  2016-11-08       Impact factor: 12.531

Review 6.  The emerging roles of ARID1A in tumor suppression.

Authors:  Ren-Chin Wu; Tian-Li Wang; Ie-Ming Shih
Journal:  Cancer Biol Ther       Date:  2014-03-11       Impact factor: 4.742

7.  SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg/CK7pos/HepPar-1pos immunophenotype.

Authors:  Abbas Agaimy; Florian Fuchs; Evgeny A Moskalev; Horia Sirbu; Arndt Hartmann; Florian Haller
Journal:  Virchows Arch       Date:  2017-05-30       Impact factor: 4.064

Review 8.  Epigenomic regulation of oncogenesis by chromatin remodeling.

Authors:  R Kumar; D-Q Li; S Müller; S Knapp
Journal:  Oncogene       Date:  2016-01-25       Impact factor: 9.867

9.  SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non-Small Cell Lung Cancer.

Authors:  Erica Hlavin Bell; Arup R Chakraborty; Xiaokui Mo; Ziyan Liu; Konstantin Shilo; Simon Kirste; Petra Stegmaier; Maureen McNulty; Niki Karachaliou; Rafael Rosell; Gerold Bepler; David P Carbone; Arnab Chakravarti
Journal:  Clin Cancer Res       Date:  2015-12-15       Impact factor: 12.531

10.  BRG1 promotes survival of UV-irradiated melanoma cells by cooperating with MITF to activate the melanoma inhibitor of apoptosis gene.

Authors:  Srinivas V Saladi; Philip G Wong; Archit R Trivedi; Himangi G Marathe; Bridget Keenen; Shweta Aras; Zi-Qi Liew; Vijayasaradhi Setaluri; Ivana L de la Serna
Journal:  Pigment Cell Melanoma Res       Date:  2013-04-02       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.